At a glance
ClinicalIndex Comparison Record- ✓Physician-diagnosed exercise-induced bronchospasm
- ✕Any significant health condition other than asthma that is not in good, stable health status
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-Blind, Randomized Multicenter, 3-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast Compared With Placebo and Salmeterol on Exercise-Induced Bronchoconstriction
In Brief
A Phase 3 clinical trial evaluating Comparator: Montelukast, Comparator: Salmeterol, and 2 other interventions for Asthma, Exercise-Induced. Completed, enrolled 47 participants.
Detailed Summary
To determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in patients who have a history of worsening asthma after exercise.
Study Details
Timeline
Interventions
1 dose montelukast 10 mg tablet given orally in one of three treatment periods
1 dose of 50 ug salmeterol given by inhalation in one of three treatment periods
1 dose matching-image placebo to montelukast tablet in two of three treatment periods
1 dose matching-image placebo of salmeterol 50 ug inhalation in two of three treatment periods